Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carotid Risk Prediction (CRISP) Consortium

NCT04448353 is registered in ClinicalTrials.gov with Elucid Bioimaging Inc. as lead sponsor.

NCT NCT04448353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carotid Risk Prediction (CRISP) Consortium
Lead sponsor
Elucid Bioimaging Inc.
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
April 30, 2022
Enrollment
800 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carotid atherosclerosis